GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DBV Technologies SA (FRA:DBV) » Definitions » Other Gross PPE

DBV Technologies (FRA:DBV) Other Gross PPE : €17.91 Mil (As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is DBV Technologies Other Gross PPE?

DBV Technologies's Other Gross PPE for the quarter that ended in Mar. 2024 was €17.91 Mil.

DBV Technologies's quarterly Other Gross PPE increased from Sep. 2023 (€13.57 Mil) to Dec. 2023 (€27.59 Mil) but then declined from Dec. 2023 (€27.59 Mil) to Mar. 2024 (€17.91 Mil).

DBV Technologies's annual Other Gross PPE declined from Dec. 2021 (€25.46 Mil) to Dec. 2022 (€21.69 Mil) but then increased from Dec. 2022 (€21.69 Mil) to Dec. 2023 (€27.59 Mil).


DBV Technologies Other Gross PPE Historical Data

The historical data trend for DBV Technologies's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DBV Technologies Other Gross PPE Chart

DBV Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 33.80 27.27 25.46 21.69 27.59

DBV Technologies Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.80 14.74 13.57 27.59 17.91

DBV Technologies Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


DBV Technologies (FRA:DBV) Business Description

Traded in Other Exchanges
Address
177-181 avenue Pierre Brossolette, Montrouge, FRA, 92120
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Viaskin targets specific antigen-presenting immune cells in the skin, called Langerhans cells, that capture the antigen and migrate to the lymph node in order to activate the immune system without passage of the antigen into the bloodstream, minimizing systemic exposure in the body. Its main product candidate is Viaskin Peanut for the treatment of peanut-allergic patients.